Sectors
ADXN
Addex Therapeutics Ltd
5.89
2 x 6.06
1 x 6.40
bid
ask
+
0.00
0.00%
6 @ 04:06 AM
6.06 +0.17 (2.89%)
| Ytd | -23.70% | |
| 1y | -37.87% |
5.89
day range
5.89
5.41
52 week range
13.27
| Open | 5.89 | Prev Close | 5.89 | Low | 5.89 | High | 5.89 | Mkt Cap | 7.33M |
| Vol | 169.00 | Avg Vol | 4.06K | EPS | N/A | P/E | N/A | Forward P/E | -159.83 |
| Beta | 1.50 | Short Ratio | 0.14 | Inst. Own | 0.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 6.48 | 200-d Avg | 7.54 | 1yr Est | 30.00 |
| Income Statement | |||
| Total Revenue | 15.83K | ||
| Revenues (USD) | 20.04K | ||
| Gross Profit | 15.83K | ||
| Operating Expenses | 795.09K | ||
| Research and Development Expense | 52.81K | ||
| Selling, General and Administrative Expense | 742.28K | ||
| Operating Income | -779.26K | ||
| Interest Expense | 1.41K | ||
| Net Income | -1.84M | ||
| Net Income Common Stock | -1.84M | ||
| Net Income Common Stock (USD) | -2.33M | ||
| Consolidated Income | -1.84M | ||
| Net Income from Discontinued Operations | 3.41K | ||
| Earnings per Basic Share | -0.01 | ||
| Earnings per Basic Share (USD) | -0.01 | ||
| Earnings per Diluted Share | -0.01 | ||
| Earning Before Interest & Taxes (EBIT) | -1.84M | ||
| Earning Before Interest & Taxes (USD) | -2.32M | ||
| Weighted Average Shares | 98.32M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.64M | ||
| Cash and Equivalents (USD) | 2.07M | ||
| Investments | 4.15M | ||
| Investments Current | 5.13K | ||
| Investments Non-Current | 4.14M | ||
| Trade and Non-Trade Receivables | 20.09K | ||
| Current Assets | 1.68M | ||
| Property, Plant & Equipment Net | 34.24K | ||
| Total Assets | 6.36M | ||
| Debt Current | 7.68K | ||
| Total Debt | 34.69K | ||
| Current Liabilities | 1.20M | ||
| Debt Non-Current | 27.01K | ||
| Total Liabilities | 1.60M | ||
| Accumulated Retained Earnings (Deficit) | -360.09M | ||
| Shareholders Equity | 4.77M | ||
| Shareholders Equity (USD) | 6.03M | ||
| Assets Non-Current | 4.68M | ||
| Total Debt (USD) | 43.91K | ||
| Liabilities Non-Current | 398.62K | ||
| Trade and Non-Trade Payables | 1.19M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.12K | ||
| Net Cash Flow from Financing | 75.67K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -547.10K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -3.40K | ||
| Issuance (Purchase) of Equity Shares | 78.50K | ||
| Issuance (Repayment) of Debt Securities | -1.86K | ||
| Net Cash Flow from Investing | -3.40K | ||
| Net Cash Flow from Operations | -619.37K | ||
| Effect of Exchange Rate Changes on Cash | -1.49K | ||